Cheviot Value Management, LLC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 1427147
BEVERLY HILLS, CA
Position in LGND
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$63,218
+$23,288 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#343
of 413 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cheviot Value Management, LLC holds $139,384 across 13 Biotechnology names. LGND ranks #1 (45.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
This page
|
200 | $63,218 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
796 | $26,976 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30 | $18,706 | |
| 4 | TECH |
BIO-TECHNE Corp
|
172 | $12,151 | |
| 5 | BHVN |
Biohaven Ltd.
|
750 | $11,160 | |
| 6 | OABI |
OmniAb, Inc.
|
980 | $2,410 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
28 | $2,220 | |
| 8 | MNKD |
Mannkind Corp
|
200 | $852 |
All Filings in LGND
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,218 | 200 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $39,930 | 200 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $37,814 | 200 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $35,428 | 200 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $22,736 | 200 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $21,028 | 200 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||